Impact of Selection of Cord Blood Units from the United States and Swiss Registries on the Cost of Banking Operations
Author(s) -
Thomas Bart,
Michael Boo,
Snejana Balabanova,
Yvonne Fischer,
Grazia Nicoloso,
Lydia Foeken,
Machteld Oudshoorn,
Jakob Passweg,
André Tichelli,
Vincent Kindler,
Joanne Kurtzberg,
Thomas H. Price,
Donna Regan,
Elizabeth J. Shpall,
Rudolf Schwabe
Publication year - 2013
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000345690
Subject(s) - cord blood , transplantation , medicine , bone marrow , stem cell , haematopoiesis , hematopoietic stem cell transplantation , immunology , biology , genetics
Over the last 2 decades, cord blood (CB) has become an important source of blood stem cells. Clinical experience has shown that CB is a viable source for blood stem cells in the field of unrelated hematopoietic blood stem cell transplantation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom